Insider Cluster (2 insiders) ·Filed Apr 16, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $276K total
Actionable Insight • Neutral

Monitor next quarterly Form 10-Q for any changes in cash runway or clinical trial progress, as insider sales remain within routine ranges and do not signal material concern. No immediate catalyst is evident from the trading pattern.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +21.86% at T+60d
NEUTRAL call ✓ call won +21.86% · α vs SPY +14.81% · entry $28.78 → $35.07
Entry anchored
Apr 15, 03:59 PM ET
via exchange tick
T+1d
-0.69%
call -0.69% · α -1.91%
$28.58
settled 6mo ago
T+5d
-5.18%
call -5.18% · α -6.16%
$27.29
settled 5mo ago
T+20d
+14.45%
call +14.45% · α +8.64%
$32.94
settled 5mo ago
T+60d
+21.86%
call +21.86% · α +14.81%
$35.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Pharvaris sold shares in the past week, including CEO Modig Berndt and CMO Lu Peng, generating a combined $276K from open-market sales. The transactions follow routine option exercises, with cashless exercises and tax-related dispositions also reported.

Key Financial Metrics

Direction
selling
Total Value
$276.2K
Insiders
2

Key Facts

  • CEO Modig Berndt sold 2,300 shares at $28.60, generating $66,780 in proceeds.
  • CMO Lu Peng sold 7,001 shares at $30.0531, generating $210,401.75 in proceeds.
  • Total open-market sales in the cluster amount to $276,181.75.
  • Additional derivative exercises and tax-withholding transactions (codes A, M, F) occurred but are non-cash events.
  • Total insider sales over the last 30 days now amount to $921K, still under 0.1% of the $1.8B market cap.

Financial Impact

$276K in total open-market sales over 7 days, representing 0.015% of market cap

insider ownershipshareholder sentiment

Risk Factors

  • Perception risk if additional executives increase selling in coming weeks.
  • Lack of insider buying may signal muted near-term conviction.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
84% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1777044469272
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 24, 2026